Pacira reported $44.9M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Astellas Pharma JPY 1.79B 101.21B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 3.12B 0 Mar/2025
Ligand Pharmaceuticals USD 19.41M 19.39M Jun/2025
Novo Nordisk 4.44B 3.99B Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025